<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>47(4)</volume><submitter>Baroncelli GI</submitter><funding>Università di Pisa</funding><pubmed_abstract>&lt;h4>Objective&lt;/h4>FGF23 measurement may have a diagnostic role to investigate patients with phosphate disorders. However, normal values for infants, children, and adolescents have not been defined.&lt;h4>Methods&lt;/h4>In a total of 282 (males 145, females 137) healthy infants (n = 30), prepubertal (n = 147), pubertal (n = 59), and postpubertal (n = 46), and in twenty patients with X-linked hypophosphatemic rickets (XLH, age 10.2 ± 5.6 years) serum phosphate (automated analyzer), and plasma intact FGF23 (immunochemiluminescent sandwich assay, DiaSorin) concentrations were measured.&lt;h4>Results&lt;/h4>Intact FGF23 concentrations were higher in healthy infants than in prepubertal (P &lt; 0.01) and postpubertal subjects (P &lt; 0.05); pubertal subjects showed higher values (P &lt; 0.05) than postpubertal subjects. Serum phosphate concentrations were higher (P &lt; 0.001) in healthy infants than in prepubertal, pubertal, and postpubertal subjects. Pubertal subjects had higher (P &lt; 0.001) serum phosphate concentrations than postpubertal subjects. Intact FGF23 and serum phosphate concentrations did not differ (P = NS) by sex, age of menarche, and time after menarche. In healthy subjects, there was no correlation between intact FGF23 and serum phosphate concentrations. Intact FGF23 concentrations were higher (P &lt; 0.0001) in patients with XLH than in healthy subjects according to chronological age and pubertal development. In all patients, intact FGF23 concentrations were above 40 pg/mL; intact FGF23 concentrations were inversely correlated with serum phosphate concentrations (r = -0.65; P &lt; 0.01).&lt;h4>Conclusion&lt;/h4>In healthy subjects, chronological age and puberty were main determinants of intact FGF23 concentrations. Intact FGF23 concentrations may be a useful marker for the early diagnosis of XLH in pediatric patients.</pubmed_abstract><journal>Journal of endocrinological investigation</journal><pagination>873-882</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10965647</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Intact FGF23 concentration in healthy infants, children, and adolescents, and diagnostic usefulness in patients with X-linked hypophosphatemic rickets.</pubmed_title><pmcid>PMC10965647</pmcid><pubmed_authors>Pelosini C</pubmed_authors><pubmed_authors>Sessa MR</pubmed_authors><pubmed_authors>Baroncelli GI</pubmed_authors><pubmed_authors>Toschi B</pubmed_authors><pubmed_authors>Peroni D</pubmed_authors><pubmed_authors>Bertelloni S</pubmed_authors><pubmed_authors>Michelucci A</pubmed_authors><pubmed_authors>Comberiati P</pubmed_authors><pubmed_authors>Piaggi P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Intact FGF23 concentration in healthy infants, children, and adolescents, and diagnostic usefulness in patients with X-linked hypophosphatemic rickets.</name><description>&lt;h4>Objective&lt;/h4>FGF23 measurement may have a diagnostic role to investigate patients with phosphate disorders. However, normal values for infants, children, and adolescents have not been defined.&lt;h4>Methods&lt;/h4>In a total of 282 (males 145, females 137) healthy infants (n = 30), prepubertal (n = 147), pubertal (n = 59), and postpubertal (n = 46), and in twenty patients with X-linked hypophosphatemic rickets (XLH, age 10.2 ± 5.6 years) serum phosphate (automated analyzer), and plasma intact FGF23 (immunochemiluminescent sandwich assay, DiaSorin) concentrations were measured.&lt;h4>Results&lt;/h4>Intact FGF23 concentrations were higher in healthy infants than in prepubertal (P &lt; 0.01) and postpubertal subjects (P &lt; 0.05); pubertal subjects showed higher values (P &lt; 0.05) than postpubertal subjects. Serum phosphate concentrations were higher (P &lt; 0.001) in healthy infants than in prepubertal, pubertal, and postpubertal subjects. Pubertal subjects had higher (P &lt; 0.001) serum phosphate concentrations than postpubertal subjects. Intact FGF23 and serum phosphate concentrations did not differ (P = NS) by sex, age of menarche, and time after menarche. In healthy subjects, there was no correlation between intact FGF23 and serum phosphate concentrations. Intact FGF23 concentrations were higher (P &lt; 0.0001) in patients with XLH than in healthy subjects according to chronological age and pubertal development. In all patients, intact FGF23 concentrations were above 40 pg/mL; intact FGF23 concentrations were inversely correlated with serum phosphate concentrations (r = -0.65; P &lt; 0.01).&lt;h4>Conclusion&lt;/h4>In healthy subjects, chronological age and puberty were main determinants of intact FGF23 concentrations. Intact FGF23 concentrations may be a useful marker for the early diagnosis of XLH in pediatric patients.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2025-04-22T16:15:09.013Z</modification><creation>2025-04-06T01:39:57.11Z</creation></dates><accession>S-EPMC10965647</accession><cross_references><pubmed>37991698</pubmed><doi>10.1007/s40618-023-02202-4</doi></cross_references></HashMap>